No new items were published in the sources we monitor on this date. The open consultations and hearings below remain current.
Federal Official Gazette
No changes.
ANS news
No changes.
Open public consultations
- CP 168. Subject: CP opened to receive criticism and suggestions regarding the proposed amendment of Normative Resolutions No. 516 and No. 521, of 2022. Deadline: Feb 23, 2026 to Apr 9, 2026.
- CP 169. Purpose: to receive contributions related to the proposed updates to the List of Health Procedures and Events (Rol). Deadline: Mar 11, 2026 to Mar 30, 2026.
Scheduled public hearings
- AP 64. Public Hearing No. 64 aims to gather contributions regarding the unfavorable preliminary recommendation for the technology: (i) UAT 193 – Olaparib as monotherapy – Treatment of adult patients with metastatic castration-resistant prostate cancer with mutations in the BRCA1 and/or BRCA2 genes, whose disease has progressed after prior treatment with a new hormonal agent. Date: March 20, 2026, from 9:30 a.m. to 11 a.m.
Open public calls for input
There is no open public call for input.
Open public calls
No updates.
Other news
– No changes.
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.